{
  "cg:id": "Ex014",
  "cg:type": "Example",
  "dataId": {
    "cg:id": "CritAssess288",
    "cg:type": "CriterionAssessment",
    "explanation": "Across publications, this variant is thought to account for 2%-10% of patients with Malignant hyperthermia. But variant is also only found in 9/66740 Europeans in ExAC (.01%). Based on these differences, groups applied PS4 to this variant classification (without a formal OR analysis).",
    "wasGeneratedBy": {
      "cg:id": "AssessCrit014",
      "cg:type": "AssessCriterion",
      "startedAtTime": "2016-06-05T14:39:00+00:00",
      "endedAtTime": "2016-06-05T14:39:00+00:00",
      "wasAssociatedWith": [
        {
          "cg:id": "Agent001",
          "cg:type": "Agent",
          "description": "SH",
          "name": "Steven Harrison"
        }
      ]
    },
    "criterion": {
      "cg:id": "PS4",
      "cg:type": "Criterion",
      "description": "The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls",
      "shortDescription": "Prevelance increase in affected v control",
      "defaultOutcome": "CG:S",
      "targetInterpretation": "LN:LA6668-3"
    },
    "variant": {
      "cg:id": "CanAll023",
      "cg:type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll026",
      "identifier": "http://reg.genome.network/allele/CA024311"
    },
    "condition": [
      {
        "cg:id": "MendCond011",
        "cg:type": "MendelianCondition",
        "explanation": "Malignant hyperthermia"
      }
    ],
    "outcome": "CG:MET",
    "hasSupportingEvidence": [
      {
        "cg:id": "EvLn020",
        "supportingData": [
          {
            "cg:id": "CaseCtrl033",
            "cg:type": "CaseControl",
            "explanation": "Did not calculate formal odds ratio",
            "canonicalAllele": {
              "cg:id": "CanAll023",
              "cg:type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll026",
              "identifier": "http://reg.genome.network/allele/CA024311"
            },
            "condition": {
              "cg:id": "MendCond011",
              "cg:type": "MendelianCondition",
              "explanation": "Malignant hyperthermia"
            },
            "caseGroupFrequency": {
              "cg:id": "AllFreq032",
              "cg:type": "AlleleFrequency",
              "explanation": "This allele is thought to account for between 2% and 10% of patients with Malignant hyperthermia.",
              "allele": {
                "cg:id": "CanAll023",
                "cg:type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll026",
                "identifier": "http://reg.genome.network/allele/CA024311"
              }
            },
            "controlGroupFrequency": {
              "cg:id": "AllFreq031",
              "cg:type": "AlleleFrequency",
              "ascertainment": "ExAC",
              "allele": {
                "cg:id": "CanAll023",
                "cg:type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll026",
                "identifier": "http://reg.genome.network/allele/CA024311"
              },
              "alleleCount": 9,
              "alleleNumber": 66740
            }
          }
        ]
      }
    ]
  },
  "index": 2,
  "authorId": {
    "cg:id": "Agent001",
    "cg:type": "Agent",
    "description": "SH",
    "name": "Steven Harrison"
  },
  "description": "Assessed variant: NM_000540.2 (RYR1):c.1840C>T (p.Arg614Cys)\n \nAcross publications, this variant is thought to account for 2%-10% of patients with Malignant hyperthermia. But variant is also only found in 9/66740 Europeans in ExAC (.01%). Based on these differences, groups applied PS4 to this variant classification (without a formal OR analysis)."
}
